Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

NASDAQ:DRTS

Overview | Financials
Company Name Alpha Tau Medical Ltd.
Symbol DRTS
Currency USD
Price 3.1
Market Cap 216,765,020
Dividend Yield 0%
52-week-range 1.75 - 3.4
Industry Biotechnology
Sector Healthcare
CEO Mr. Uzi Sofer
Website https://www.alphatau.com

An error occurred while fetching data.

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical

Related Stocks

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

12.79 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

0.422 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.95 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.195 USD

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

76.52 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.91 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

42.6 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

2.06 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.62 USD

Financials

Numbers are in millions USD

Numbers are in millions USD